It is well known that a majority of patients with non-valvular atrial fibrillation (NVAF) treated with vitamin K antagonists (VKA) do not benefit from bridging anticoagulation for ambulatory procedures [1–3]. Conversely, there is little evidence around overlapping low-molecular weight heparin (LMWH) with VKA when starting anticoagulation, despite it being common practice. The present study aimed to describe the frequency of use of an overlapping strategy and determine the incidence of bleeding and thrombotic events based on whether this strategy or VKA were used.
